Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Barrier Therapeutics

2001 FOUNDED
M&A STATUS
101-200 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
6 FINANCING ROUNDS
Description

Developer and manufacturer of pharmaceuticals for dermatological therapeutics. The company provides Xolegel, a topical gel for the treatment of seborrheic dermatitis and Vusion, a topical ointment for the treatment of infants and children with diaper dermatitis.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 600 College Road East
  • Suite 3200
  • Princeton, NJ 08540
  • United States

Barrier Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Barrier Therapeutics‘s full profile, request access.

Request full access to PitchBook

Barrier Therapeutics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Barrier Therapeutics‘s full profile, request access.

Request full access to PitchBook

Barrier Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
000000000 00000 Self Board Member 000 0000
00000 0000000 Self Chairman 000 0000